Correlation Between Laboratory and Compass Pathways

Can any of the company-specific risk be diversified away by investing in both Laboratory and Compass Pathways at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Laboratory and Compass Pathways into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Laboratory of and Compass Pathways Plc, you can compare the effects of market volatilities on Laboratory and Compass Pathways and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Laboratory with a short position of Compass Pathways. Check out your portfolio center. Please also check ongoing floating volatility patterns of Laboratory and Compass Pathways.

Diversification Opportunities for Laboratory and Compass Pathways

-0.61

Correlation Coefficient

Laboratory  Compass Pathways

Excellent diversification

The 3 months correlation between Laboratory and Compass is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Laboratory of and Compass Pathways Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compass Pathways Plc and Laboratory is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Laboratory of are associated (or correlated) with Compass Pathways. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compass Pathways Plc has no effect on the direction of Laboratory i.e., Laboratory and Compass Pathways go up and down completely randomly.

Pair Corralation between Laboratory and Compass Pathways

Allowing for the 90-day total investment horizon Laboratory of is expected to generate 0.21 times more return on investment than Compass Pathways. However, Laboratory of is 4.86 times less risky than Compass Pathways. It trades about -0.17 of its potential returns per unit of risk. Compass Pathways Plc is currently generating about -0.08 per unit of risk. If you would invest  23,600  in Laboratory of on October 8, 2024 and sell it today you would lose (685.00) from holding Laboratory of or give up 2.9% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Laboratory of  vs.  Compass Pathways Plc

Laboratory

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Laboratory of are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak technical indicators, Laboratory may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Compass Pathways Plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Compass Pathways Plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Laboratory and Compass Pathways

The main advantage of trading using opposite Laboratory and Compass Pathways positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Laboratory position performs unexpectedly, Compass Pathways can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compass Pathways will offset losses from the drop in Compass Pathways' long position.

The idea behind Laboratory of and Compass Pathways Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.